Lidocaine HCL 2% 25S
Ended Awarded Last action
- Contract number
- SPE2DR26FHYW0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,545
Award facts
- Contract value 100% obligated
- $2,545.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $2,545.22 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for Lidocaine HCL 2% (25 units). The award, issued on December 19, 2025, with an ultimate completion date of January 20, 2026, carries no set-aside designation, indicating the contractor competed in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (SPE2DR) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion government-wide acquisition strategy established to streamline pharmaceutical procurement for Department of Defense healthcare facilities.
DMS Pharmaceutical Group has demonstrated substantial capacity as a critical pharmaceutical supplier within the federal military medical supply chain, with the parent IDC featuring a ceiling value of $499,999,999 and extending through December 31, 2036. The company's comprehensive product portfolio spans branded and generic pharmaceuticals, biologics, vaccines, specialty medications, and medical consumables, positioning it to support the diverse pharmaceutical requirements of DoD healthcare operations globally. This delivery order for local anesthetic medication exemplifies the routine pharmaceutical replenishment orders issued under the PPV-G GEN V initiative to maintain consistent medical supply availability across military healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FHYW0?
SPE2DR26FHYW0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 19, 2025.
How much is contract SPE2DR26FHYW0 worth?
The government has obligated $2,545 on SPE2DR26FHYW0.
Is contract SPE2DR26FHYW0 an order under another contract?
Yes. SPE2DR26FHYW0 is a delivery order under SPE2DR25D9762, an indefinite delivery contract.
Was contract SPE2DR26FHYW0 competed?
The extent of competition for SPE2DR26FHYW0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award